Post Featured Image
Post Featured Image

New Treatment For Canine Arthritis

Thereโ€™s a very cool new regenerative treatment that can help!

Last Updated:

Share:

Does your dog have early onset osteoarthritis? Or tissue-related injuries like corneal ulcers, tendon and ligament injuries, joint issues, or superficial wounds? If so, thereโ€™s a very cool new regenerative treatment that can help! Biotech company AniCell, which spent years working on acellular regenerative therapy with horses, has now launched a product for dogs. CanisCell uses amniotic components to stimulate the bodyโ€™s own restoration capabilities to regrow healthy tissue and bone. The amniotic material in their products is collected non-invasively during the births of happy, healthy puppies. When administered to damaged areas like joints, these regenerative, biologic treatments accelerate the healing of connective tissue and bone.

โ€œVeterinarians need treatments that can be used on challenging cases that are both chronic and acute in nature, not products that just treat symptoms,โ€ says AniCellโ€™s bioprocess engineer and research veterinarian, Dr. Moises Barcelo. โ€œOur lines are regenerating tissue systemically at the scaffold level and doing it in superficial lacerations, ligament lesions, tendon injuries, and ocular ulcers through a single use application.โ€

Dr. Jeffery Richman, DVM of the Richman Animal Clinic in Richmond Heights, Ohio, has seen the results first hand. โ€œAfter the intravenous CanisCell (for spondylosis) which took less than an hour in an IV infusion, Coop [his canine patient] has significant improvement. He can go for walks, is less painful and most of all seems happier.โ€

Interested in trying it? The cost is approximately $300 for eye injuries, $1000 for joint treatments, $1500 for tendon and ligament treatments, and $200-500 for superficial wounds. Talk to your vet if you think this could be a fit for your dog. Find out more at anicellbiotech.com.

Comments (0)

Join the newsletter and never miss out on dog content again!

"*" indicates required fields

Consent*
This field is for validation purposes and should be left unchanged.

By clicking the arrow, you agree to our web Terms of Use and Privacy & Cookie Policy. Easy unsubscribe links are provided in every email.